SEC Comment Letter for Inhibitor Therapeutics, Inc. (INTI) (CIK 0001042418) (INTI) — Feb 27, 2009
Inhibitor Therapeutics, Inc. (INTI) (CIK 0001042418)
Date: Feb. 27, 2009 · CIK: 0001042418 · Accession: 0000000000-09-010395
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 000-06334
Letter
Via Facsimile and U.S. Mail Mail Stop 6010 February 27, 2009 Mr. James H. Brennan Commonwealth Biotechnologies, Inc. Vice President Financial Operations 601 Biotech Drive Richmond, Virginia 23235 Re: Commonwealth Biotechnologies, Inc. Item 4.01 Form 8-K Filed February 24, 2009 File No. 000-06334
Dear Mr. Brennan:
We have completed our review of your Form 8-K and have no further comments at this time.
S i n c e r e l y , T a b a t h a A k i n s S t a f f A c c o u n t a n t
Show Raw Text
Via Facsimile and U.S. Mail Mail Stop 6010 February 27, 2009 Mr. James H. Brennan Commonwealth Biotechnologies, Inc. Vice President Financial Operations 601 Biotech Drive Richmond, Virginia 23235
Re: Commonwealth Biotechnologies, Inc.
Item 4.01 Form 8-K
Filed February 24, 2009
File No. 000-06334
Dear Mr. Brennan:
We have completed our review of your Form 8-K and have no further comments
at this time.
S i n c e r e l y , T a b a t h a A k i n s S t a f f A c c o u n t a n t